www.boostimmune.com

The startup develops inhibitors targeting myeloid-derived suppressor cells (MDSCs) to enhance T cell activity within the tumor microenvironment. This approach aims to improve the immune response against cancer cells, facilitating more effective immuno-oncology treatments.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup develops inhibitors targeting myeloid-derived suppressor cells (MDSCs) to enhance T cell activity within the tumor microenvironment. This approach aims to improve the immune response against cancer cells, facilitating more effective immuno-oncology treatments.